Jon Salmanton-García
@salmantongarcia.bsky.social
PostDoc @uniklinikkoeln.bsky.social and @cecad.bsky.social
#FECMM
@efisg-escmid.bsky.social Chair 2024-26
YoungEHA Committee member 2025-
@fungiscope.bsky.social #VACCELERATE #EPICOVIDEHA
#hematology #mycoses #ViralRespiratoryInfections
#FECMM
@efisg-escmid.bsky.social Chair 2024-26
YoungEHA Committee member 2025-
@fungiscope.bsky.social #VACCELERATE #EPICOVIDEHA
#hematology #mycoses #ViralRespiratoryInfections
Reposted by Jon Salmanton-García
🧫 Clinical insights into #mucormycosis in immunosuppressed patients:
A multicentre study from Northern Argentina shows that timely care and targeted antifungals-especially liposomal amphotericin B-significantly improve survival.
#FungalInfections #InfectiousDiseases @salmantongarcia.bsky.social
A multicentre study from Northern Argentina shows that timely care and targeted antifungals-especially liposomal amphotericin B-significantly improve survival.
#FungalInfections #InfectiousDiseases @salmantongarcia.bsky.social
November 20, 2025 at 6:22 AM
🧫 Clinical insights into #mucormycosis in immunosuppressed patients:
A multicentre study from Northern Argentina shows that timely care and targeted antifungals-especially liposomal amphotericin B-significantly improve survival.
#FungalInfections #InfectiousDiseases @salmantongarcia.bsky.social
A multicentre study from Northern Argentina shows that timely care and targeted antifungals-especially liposomal amphotericin B-significantly improve survival.
#FungalInfections #InfectiousDiseases @salmantongarcia.bsky.social
Reposted by Jon Salmanton-García
New nationwide ESCMID-EFISG study on fungal infection care in Colombia: major gaps in diagnostics, limited access to advanced tools & antifungals, with strong urban–rural disparities. www.sciencedirect.com/science/arti... @salmantongarcia.bsky.social @escmid.bsky.social @efisg-escmid.bsky.social
Diagnostic and therapeutic capacity for fungal infections in Colombia: An ESCMID-EFISG nationwide multicenter assessment of mycological healthcare
This study aims to evaluate nationwide diagnostic and treatment capacity for IFD across Colombia’s diverse healthcare system.Between March and Septemb…
www.sciencedirect.com
November 27, 2025 at 8:37 AM
New nationwide ESCMID-EFISG study on fungal infection care in Colombia: major gaps in diagnostics, limited access to advanced tools & antifungals, with strong urban–rural disparities. www.sciencedirect.com/science/arti... @salmantongarcia.bsky.social @escmid.bsky.social @efisg-escmid.bsky.social
Reposted by Jon Salmanton-García
#EFISG webinars and more...
www.clinicalsurveys.net/uc/EFISG_web...
2025
18/11, +@ESGAP_ABS Antifungal stewardship
11–12/12, XII Mycological Forum🇪🇸
16/12, Dermatophytes dx and tx
17/12, Dengue in hem/onc
22/12, IDWeek and CHEST hightlights
2026
20/01, Taxonomy
17/01, Point-of-care dx
www.clinicalsurveys.net/uc/EFISG_web...
2025
18/11, +@ESGAP_ABS Antifungal stewardship
11–12/12, XII Mycological Forum🇪🇸
16/12, Dermatophytes dx and tx
17/12, Dengue in hem/onc
22/12, IDWeek and CHEST hightlights
2026
20/01, Taxonomy
17/01, Point-of-care dx
November 12, 2025 at 8:39 AM
#EFISG webinars and more...
www.clinicalsurveys.net/uc/EFISG_web...
2025
18/11, +@ESGAP_ABS Antifungal stewardship
11–12/12, XII Mycological Forum🇪🇸
16/12, Dermatophytes dx and tx
17/12, Dengue in hem/onc
22/12, IDWeek and CHEST hightlights
2026
20/01, Taxonomy
17/01, Point-of-care dx
www.clinicalsurveys.net/uc/EFISG_web...
2025
18/11, +@ESGAP_ABS Antifungal stewardship
11–12/12, XII Mycological Forum🇪🇸
16/12, Dermatophytes dx and tx
17/12, Dengue in hem/onc
22/12, IDWeek and CHEST hightlights
2026
20/01, Taxonomy
17/01, Point-of-care dx
Today in Rome 🇮🇹, at #LaboratorioSEIFEM, we discussed #hMPV and #RSV in hematology patients
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
November 11, 2025 at 11:24 AM
Today in Rome 🇮🇹, at #LaboratorioSEIFEM, we discussed #hMPV and #RSV in hematology patients
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
Still looking for cases of viral respiratory infections 🦠 of any kind within #EPICOVIDEHA / #EPIRESEHA 🧬
Always a pleasure to exchange ideas with our Italian colleagues! 🇮🇹
#Porto was alive with science! 🧫✨ From parasites to fungi, or endemic viruses... — great talks, great people, great vibes. Grateful to the organizing team for the kind invite!
November 8, 2025 at 6:45 PM
#Porto was alive with science! 🧫✨ From parasites to fungi, or endemic viruses... — great talks, great people, great vibes. Grateful to the organizing team for the kind invite!
🇨🇴 New @efisg-escmid.bsky.social study... Diagnostic and therapeutic capacity for fungal infections in #Colombia
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
November 4, 2025 at 8:23 AM
🇨🇴 New @efisg-escmid.bsky.social study... Diagnostic and therapeutic capacity for fungal infections in #Colombia
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
Findings show critical inequities in access to mycology labs, antifungal drugs, and @who.int-recommended diagnostics.
Full study 👉 www.sciencedirect.com/science/arti...
🧬 COVID showed us the importance of viral vigilance—but respiratory infections go far beyond it.
Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more:
youtu.be/C2LTcEDnAoI?...
Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more:
youtu.be/C2LTcEDnAoI?...
EPIRESEHA Webinar: Insights and Perspectives on Viral Respiratory Infections
YouTube video by IDIM IDIM
youtu.be
October 29, 2025 at 12:54 PM
🧬 COVID showed us the importance of viral vigilance—but respiratory infections go far beyond it.
Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more:
youtu.be/C2LTcEDnAoI?...
Catch the latest EPICOVIDEHA-EPIRESEHA webinar on influenza, RSV, hMPV and more:
youtu.be/C2LTcEDnAoI?...
🚨 Final #DGHO2025 @dgho_ev day!
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
October 26, 2025 at 9:38 PM
🚨 Final #DGHO2025 @dgho_ev day!
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
Mon, Oct 27 (from 15:45, poster area)
🧬P1301 – Respiratory viruses in hem/onc
🦠P1303 – hMPV vs Influenza vs SARS-CoV-2
🧫P1304 – RSV vs Influenza vs SARS-CoV-2
🇵🇪P1305 – IFI dx and tx capacity - Peru
🇭🇳P1306– IFI dx and tx capacity - Honduras
Double dose of infection science today at #DGHO2025! 🧪
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
October 26, 2025 at 8:56 AM
Double dose of infection science today at #DGHO2025! 🧪
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🕚 11:00 (S/T rooms) – Ceftazidim-avibactam in action
🕕 18:55 (Poster area) – Antifungal stewardship spotlight
@dgho_ev
🌎 From Argentina to Germany! 🇦🇷➡️🇩🇪 4 posters sharing real-world infectious disease insights at @dgho_eV #DGHO2025
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
October 25, 2025 at 3:14 PM
🌎 From Argentina to Germany! 🇦🇷➡️🇩🇪 4 posters sharing real-world infectious disease insights at @dgho_eV #DGHO2025
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
🗓️ Sat, 25 Oct | 17:45 | Postehalle
🦟 P416 #Dengue in hem/onc
🍄 P417 #Mucorales experience
💊 P418 #ISAV introduction
🧫 P419 #Aspergillus experience
🧫 Persistent candidemia: lessons from a European cohort
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
October 17, 2025 at 8:43 AM
🧫 Persistent candidemia: lessons from a European cohort
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%).
Low EQUAL #Candida Scores predicted persistence
💡 Adherence saves lives
🔗 www.journalofinfection.com/article/S016...
“Beyond the Guidelines: Managing invasive fungal infections in critical illness” 🧫
Revisit to the 2024 ATS recommendations on:
1️⃣ Combination therapy for IPA
2️⃣ Empirical/prophylactic treatment for IC in ICU
👉 www.sciencedirect.com/science/arti...
Revisit to the 2024 ATS recommendations on:
1️⃣ Combination therapy for IPA
2️⃣ Empirical/prophylactic treatment for IC in ICU
👉 www.sciencedirect.com/science/arti...
Managing invasive fungal infections in critical illness: reflections on recent American Thoracic Society recommendations
www.sciencedirect.com
October 17, 2025 at 8:31 AM
“Beyond the Guidelines: Managing invasive fungal infections in critical illness” 🧫
Revisit to the 2024 ATS recommendations on:
1️⃣ Combination therapy for IPA
2️⃣ Empirical/prophylactic treatment for IC in ICU
👉 www.sciencedirect.com/science/arti...
Revisit to the 2024 ATS recommendations on:
1️⃣ Combination therapy for IPA
2️⃣ Empirical/prophylactic treatment for IC in ICU
👉 www.sciencedirect.com/science/arti...
Reposted by Jon Salmanton-García
Last Friday (Oct 15), @salmantongarcia.bsky.social spoke in Porto at the 1st Course on Invasive Fungal Infections, endorsed by the @EFISG-ESCMID Fungal Infection Study Group, sharing insights on the epidemiology and clinical challenges in HIV and other immunocompromised individuals. #IFIs #EFISG
October 13, 2025 at 12:46 PM
Last Friday (Oct 15), @salmantongarcia.bsky.social spoke in Porto at the 1st Course on Invasive Fungal Infections, endorsed by the @EFISG-ESCMID Fungal Infection Study Group, sharing insights on the epidemiology and clinical challenges in HIV and other immunocompromised individuals. #IFIs #EFISG
Reposted by Jon Salmanton-García
We have some exciting news to share! Out #YISHAMERS
@salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social
We are so glad to share this information and the QR codes for you to join to each of the following meetings
@salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social
We are so glad to share this information and the QR codes for you to join to each of the following meetings
October 12, 2025 at 7:26 PM
We have some exciting news to share! Out #YISHAMERS
@salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social
We are so glad to share this information and the QR codes for you to join to each of the following meetings
@salmantongarcia.bsky.social, wants to extend an invitation for all of us to join the webinars courtesy of @efisg-escmid.bsky.social
We are so glad to share this information and the QR codes for you to join to each of the following meetings
Work, science, and great vibes in Porto. Always a pleasure to come back :)
October 11, 2025 at 6:22 PM
Work, science, and great vibes in Porto. Always a pleasure to come back :)
SAVE THE DATE
📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections
F. Marchesi, IT – #Influenza
J. Salmanton-García, DE – #RSV
M. Biernat, PL – #hMPV
B. Weinbergerova, CZ – #Other_viruses
uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg
📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections
F. Marchesi, IT – #Influenza
J. Salmanton-García, DE – #RSV
M. Biernat, PL – #hMPV
B. Weinbergerova, CZ – #Other_viruses
uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg
October 9, 2025 at 6:32 AM
SAVE THE DATE
📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections
F. Marchesi, IT – #Influenza
J. Salmanton-García, DE – #RSV
M. Biernat, PL – #hMPV
B. Weinbergerova, CZ – #Other_viruses
uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg
📅 Oct 22, 2025 | 16:00 CET | #EPIRESEHA: Insights and perspectives on viral #respiratory_infections
F. Marchesi, IT – #Influenza
J. Salmanton-García, DE – #RSV
M. Biernat, PL – #hMPV
B. Weinbergerova, CZ – #Other_viruses
uni-koeln.zoom.us/meeting/register/r0LvqJ95QNWZuYhJXbUAIg
@efisg-escmid.bsky.social news...
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
October 9, 2025 at 5:37 AM
@efisg-escmid.bsky.social news...
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
#Fluco-R #Candida_parapsilosis is a growing threat in hospitals.
In a #multicenter matched cohort study, #echinocandins and #LAmB showed comparable outcomes for bloodstream infections
journals.asm.org/doi/epub/10....
@escmid.bsky.social @taescmid.bsky.social
Reposted by Jon Salmanton-García
Today & tomorrow in Madrid: the Invasive Fungal Infections Course 🦠 (Oct 1–2, 16:00–19:30 CET) at Hospital Gregorio Marañón. Free & online! 🔗 docs.google.com/forms/d/e/1F...
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
October 1, 2025 at 10:44 AM
Today & tomorrow in Madrid: the Invasive Fungal Infections Course 🦠 (Oct 1–2, 16:00–19:30 CET) at Hospital Gregorio Marañón. Free & online! 🔗 docs.google.com/forms/d/e/1F...
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
| In Spanish | with EFISG | @salmantongarcia.bsky.social on site 📸
📢 Join us on 22 Oct 2025, 16:00–18:00 CEST for the #EPIRESEHA Webinar: Insights on Viral Respiratory Infections!
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
September 30, 2025 at 12:43 PM
📢 Join us on 22 Oct 2025, 16:00–18:00 CEST for the #EPIRESEHA Webinar: Insights on Viral Respiratory Infections!
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🦠 Explore #RSV, #influenza, #hMPV and more in hematology with experts
@olivercornely.bsky.social @salmantongarcia.bsky.social
Register 👉 uni-koeln.zoom.us/meeting/regi...
🚨 Call for Papers 🚨
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
September 29, 2025 at 8:24 AM
🚨 Call for Papers 🚨
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
🔬 @BioMedCentral #Immunology is inviting submissions for our Collection on #Fungal Infections!
📅 Deadline: 26 June 2026
🌍 Topics:
Fungal pathogenesis
Immune responses
Antifungals
Precision medicine
& more...
👉 Submit here: www.biomedcentral.com/collections/...
Knowledge and capacity is not enough — it must be shared.
Over half the world is still waiting… and people are dying. Let’s act now.
Over half the world is still waiting… and people are dying. Let’s act now.
Today at #TIMM2025, @salmantongarcia.bsky.social inspired us with his vision for equitable fungal diagnostics 🌍🧫 – and even more special, he shared his birthday 🎂 with the community. Happy Birthday, Jon!
September 25, 2025 at 4:44 AM
Knowledge and capacity is not enough — it must be shared.
Over half the world is still waiting… and people are dying. Let’s act now.
Over half the world is still waiting… and people are dying. Let’s act now.
September 25, 2025 at 4:42 AM
📊 #Rezafungin in real life 🌍🇪🇺🇺🇸
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
September 18, 2025 at 10:58 AM
📊 #Rezafungin in real life 🌍🇪🇺🇺🇸
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!
onlinelibrary.wiley.com/doi/epdf/10....
🦠 Calling all #hematology researchers!
Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care
🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...
@frontiersin.bsky.social
Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care
🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...
@frontiersin.bsky.social
Frontiers | Infections in Hematology: Advances in Diagnosis, Management, and Prevention in Benign and Malignant Disorders
Infections remain a leading cause of morbidity and mortality in patients with hematologic disorders, ranging from benign cytopenias to aggressive hematologic...
frontiersin.org
September 16, 2025 at 2:03 PM
🦠 Calling all #hematology researchers!
Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care
🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...
@frontiersin.bsky.social
Submit your work to #Infections in #Hematology:
Advances in
#Diagnosis
#Management
#Prevention
#Patient_care
🗓️ Manuscript summary: 15 Dec 2025
🗓️ Full submission: 4 Apr 2026
🔗 frontiersin.org/research-top...
@frontiersin.bsky.social
Reposted by Jon Salmanton-García
📢 Presented at #MYK2025 by @salmantongarcia.bsky.social : Current trends on antifungal prophylaxis in solid organ transplantation – an ESCMID/SEIMC study exploring real-world practices to guide IFI management in transplant centers. #Transplant #Antifungals
September 16, 2025 at 8:42 AM
📢 Presented at #MYK2025 by @salmantongarcia.bsky.social : Current trends on antifungal prophylaxis in solid organ transplantation – an ESCMID/SEIMC study exploring real-world practices to guide IFI management in transplant centers. #Transplant #Antifungals